<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100-vaccines-08-00224">
 <label>100.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Castagnoli</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Votto</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Licari</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Brambilla</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Bruno</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Perlini</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rovida</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Baldanti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Marseglia</surname>
    <given-names>G.L.</given-names>
   </name>
  </person-group>
  <article-title>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review</article-title>
  <source>JAMA Pediatr.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.1467</pub-id>
 </element-citation>
</ref>
